Effects of Genistein, Apigenin, Quercetin, Rutin and Astilbin on xanthine oxidase activities and serum uric acid levels in hyperuricemic mice

Chinese Pharmacological Bulletin

Volumn 27, Issue 4, 2011, Pages 561-565

  Huang, Jing Qun ^a   Zhu, Miao Zhang ^a   Wang, Si Wang ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Apigenin; Astilbin; Flavonoids; Genistein; Gout; Hyperuricemia; Quercetin; Rutin; Xanthine oxidase

Indexed keywords

ALLOPURINOL; APIGENIN; ASTILBIN; GENISTEIN; OTERACIL POTASSIUM; PHOSPHOTUNGSTIC ACID; QUERCETIN; RUTOSIDE; URIC ACID; XANTHINE OXIDASE;

ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC KIT; DRUG EFFECT; ENZYME ACTIVITY; HYPERURICEMIA; IN VITRO STUDY; LIVER; MOUSE; NONHUMAN; SPECTROPHOTOMETRY; URIC ACID BLOOD LEVEL;

EID: 79960106741     PISSN: 10011978     EISSN: None     Source Type: Journal    
DOI: 10.3969/j.issn.1001-1978.2011.04.028     Document Type: Article

References (21)

1. Roddy E, Zhang W, Doherty M. The changing epidemiology of gout[J]. Nat Clin Pract Rheumatol, 2007, 3(8): 443-9.
2. Wu E Q, Patel P A, Yu A P, et al. Disease-related and all-cause health care costs of elderly patients with gout[J]. J Manag Care Pharm, 2008, 14(2): 164-75. (Pubitemid 351453817)
3. Short R A, Tuttle K R. Clinical evidence for the influence of uric acid on hypertension, cardiovascular disease, and kidney disease: a statistical modeling perspective[J]. Semin Nephrol, 2005, 25 (1): 25-31. (Pubitemid 40128145)
4. Heinig M, Johnson R J. Role of uric acid in hypertension, renal disease, and metabolic syndrome[J]. Cleve Clin J Med, 2006, 73 (12): 1059-64. (Pubitemid 44883981)
5. Choi H K, Ford E S. Prevalence of the metabolic syndrome in individuals with hyperuricemia[J]. Am J Med, 2007, 120(5): 442-7. (Pubitemid 46656248)
6. Terkeltaub R A. Clinical practice, Gout[J]. N Engl J Med, 2003, 349(17): 1647-55.
7. Ramallo I A, Zacchino S A, Furlan R L. A rapid TLC autographic method for the detection of xanthine oxidase inhibitors and superoxide scavengers[J]. Phytochem Anal, 2006, 17(1): 15-9. (Pubitemid 43141392)
8. Unno T, Sugimoto A, Kakuda T. Xanthine oxidase inhibitors from the leaves of Lagerstroemia speciosa (L) Pers [J]. J Ethnopharmacol, 2004, 93(2-3): 391-5. (Pubitemid 38962435)
9. Lin C M, Chen C S, Chen C T, et al. Molecular modeling of flavonoids that inhibits xanthine oxidase [J]. Biochem Biophys Res Commun, 2002, 294(1): 167-72.
10. Van Hoorn D E, Nijveldt R J, Van Leeuwen P A, et al. Accurate prediction of xanthine oxidase inhibition based on the structure of flavonoids[J]. Eur J Pharmacol, 2002, 451(2): 111-8. (Pubitemid 35253949)
11. Umamaheswari M, AsokKumar K, Somasundaram A, et al. Xanthine oxidase inhibitory activity of some Indian medical plants[J]. J Ethnopharmacol, 2007, 109(3): 547-51. (Pubitemid 46084843)
12. Murugaiyah V, Chan K L. Mechanisms of antihyperuricemic effect of Phyllanthus niruri and its lignan constituents[J]. J Ethnopharmacol, 2009, 124(2): 233-9.
13. Stavric B, Clayman S, Gadd R E, et al. Some in vivo effects in the rat induced by chloprothixene and potassium oxonate[J]. Pharmacol Res Commun, 1975, 7(2): 117-24.
14. Zhao X, Zhu J X, Mo S F, et al. Effect of cassia oils on serum and hepatic uric acid levels in oxonate-induced mice and xanthine dehydrogenase and xanthine oxidase activities in mouse liver[J]. J Ethnophare, 2006, 103(3): 357-65. (Pubitemid 43143370)
15. Carroll J J, Roberta Douglass H C, Badson A L. A simplified alkaline phosphotungstate assay for uric acid in serum[J]. Clin Chem, 1971, 17: 158-60.
16. Kong L D, Yang C, Ge F, et al. A Chinese herbal medicine Ermiao wan reduces serum uric acid level and inhibits liver xanthine dehydrogenase and xanthine oxidase in mice[J]. J Ethnopharmacol, 2004, 93(2-3): 325-30. (Pubitemid 38962424)
17. Nagao A, Seki M, Kobayashi H. Inhibition of xanthine oxidase by flavonoids[J]. Biosci Biotechnol Biochem, 1999, 63(10): 1787-90.
18. Sampson L, Ritnm E, Hollman P C, et al. Flavonol and flavone intakes in US health professionals[J]. J Am Diet Assoc, 2002, 102 (10): 1414-20. (Pubitemid 40445675)
19. Hall I H, Scoville J P, Reynolds D J, et al. Substituted cyclic imides as potencial anti-gout agents[J]. Life Sci, 1990, 46(26): 1923-7. (Pubitemid 20205064)
20. Nishioka H, Fujii H, Sun B, et al. Comparative efficacy of oligonol, catechin and (-)-epigallocatechin 3-O-gallate in modulating the potassium bromate-induced renal toxicity in rats[J]. Toxicology, 2006, 226(2-3): 181-7. (Pubitemid 44287168)
21. Wang L J, Gong T, Wang L, et al. Inhibition effect of quercetin on cell death in human bronchial epithelial cells induced by cigarette smoke extract[J]. Chin Pharmacol Bull, 2009, 25:(7): 960-3.